2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Ian S. Goldlust, BS

Investigator
National Center for Advancing Translational Sciences
Building B, Room 3005
Rockville, MD
USA 20850-3370

Papers:
517 High-throughput matrix screening in ovarian cancer cells identifies synergistic drug combinations with the second mitochondrial-derived activator of caspases (SMAC) mimetic birinapant (TL32711)